![](https://mdgroup.com/wp-content/uploads/2023/10/Blog_FDA-issues_26Sep23-1-600x300.jpg)
The FDA Draft Guidance for the Industry – A Welcome Development
Posted | October 16, 2023Nearly two years on from the COVID-19 Pandemic, and in that time, the clinical trials landscape has experienced some seismic shifts. In 2020 alone, active decentralised trials increased by more…